drugset / Trial / NCT00446836
Efficacy and Safety Study of Xyotax to Treat Prostate Cancer
Phase 2
Completed
29 enrolled
The Methodist Hospital Research Institute
Cellular Therapeutics · collab
NaSingle-groupOpen-labelTreatment
Summary
The purpose of this study is to determine whether Xyotax, a conjugate of the taxane drug paclitaxel, is effective in the treatment of prostate cancer that is no longer responsive to hormone therapy.
Timeline
- Start
- 2005-03
- Primary completion
- 2007-11
- Completion
- 2008-01
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Paclitaxel polyglumex | Unknown | — | — |